Entering text into the input field will update the search result below

Peregrine Pharmaceuticals EPS in-line, beats on revenue

  • Peregrine Pharmaceuticals (PPHM): FQ1 EPS of -$0.08 in-line.
  • Revenue of $9.67M (+75.8% Y/Y) beats by $2.64M.
  • Press Release

Recommended For You

More Trending News

About CDMO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CDMO--
Avid Bioservices, Inc.